Mal Irvine
Impact in
-
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
-
- Melanoma and MAPK Pathways
- RNA Interference and Gene Delivery
Papers in
-
- Melanoma and MAPK Pathways 3
- Retinal Development and Disorders 2
- Ubiquitin and proteasome pathways 1
- Oncology 6
- Cancer-related Molecular Pathways 3
- Cancer Immunotherapy and Biomarkers 3
- PARP inhibition in cancer therapy 1
- Co-authors
- Helen Rizos (11 shared papers)Richard Kefford (7 shared papers)Bernadette Pedersen (5 shared papers)Ashleigh Stewart (5 shared papers)Suzanah C. Boyd (2 shared papers)Richard A. Scolyer (4 shared papers)Matteo S. Carlino (4 shared papers)Georgina V. Long (3 shared papers)
In The Last Decade
Mal Irvine
11 papers receiving 360 citations
Peers
Comparison fields: 5 of 55
- Oncology 147
- Molecular Biology 249
- Immunology 68
- Cancer Research 45
- Cell Biology 34
Countries citing papers authored by Mal Irvine
This map shows the geographic impact of Mal Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mal Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mal Irvine more than expected).
Fields of papers citing papers by Mal Irvine
This network shows the impact of papers produced by Mal Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mal Irvine. The network helps show where Mal Irvine may publish in the future.
Co-authors
The 25 scholars most cited alongside Mal Irvine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 78 | |
| 2 | 2018 | 74 | |
| 3 | 2014 | 55 | |
| 4 | 2010 | 52 | |
| 5 | 2010 | 27 | |
| 6 | 2019 | 26 | |
| 7 | 2007 | 23 | |
| 8 | 2010 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 2 | |
| 11 | 2019 | 1 |
About Mal Irvine
Mal Irvine is a scholar working on Molecular Biology, Oncology, Ophthalmology, Immunology and Epidemiology, having authored 11 papers that have together received 364 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers), Retinal Development and Disorders (2 papers), Ocular Oncology and Treatments (2 papers), PARP inhibition in cancer therapy (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (147 citations), Molecular Biology (249 citations), Immunology (68 citations), Cancer Research (45 citations) and Cell Biology (34 citations). Mal Irvine has collaborated with scholars based in Australia, Germany and Brazil. Frequent co-authors include Helen Rizos, Richard Kefford, Bernadette Pedersen, Ashleigh Stewart, Suzanah C. Boyd, Richard A. Scolyer, Matteo S. Carlino, Georgina V. Long, Therese M. Becker and Carina Fung. Their work appears in journals such as Cell Cycle, Nature Communications, Clinical Cancer Research, Oncogenesis and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.